Compounds > dacarbazine

dacarbazine and 3,4-dihydro-5-methyl-1(2h)-isoquinolinone

dacarbazine has been researched along with 3,4-dihydro-5-methyl-1(2h)-isoquinolinone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boulton, S; Curtin, NJ; Durkacz, BW; Golding, BT; Griffin, RJ; Pemberton, LC; Porteous, JK1
Chatterjee, S; Gerson, SL; Liu, L; Taverna, P; Whitacre, CM1

Other Studies

2 other study(ies) available for dacarbazine and 3,4-dihydro-5-methyl-1(2h)-isoquinolinone

ArticleYear
Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors.
    British journal of cancer, 1995, Volume: 72, Issue:4

    Topics: Animals; Antineoplastic Agents; Cell Survival; Dacarbazine; DNA Damage; Drug Synergism; Enzyme Inhibitors; Isoquinolines; Mice; NAD; Poly(ADP-ribose) Polymerase Inhibitors; Temozolomide

1995
Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:10

    Topics: Antineoplastic Agents, Alkylating; Carmustine; Cell Cycle; Colonic Neoplasms; Dacarbazine; DNA Repair; Drug Synergism; Humans; Hydroxylamines; Isoquinolines; Poly(ADP-ribose) Polymerase Inhibitors; Temozolomide

1999